glp 1 benefits Frontiers EASD 2018: benefits of GIP/GLP-1

Compared to basal-bolus insulin therapy, insulin/GLP-1 drugs offer a simple and safe approach to managing titration, Billings said

3,19 On this basis, the long-acting GLP-2 mimetic, teduglutide, has gained clinical approval for short bowel syndrome

Treatment and Dosing With Tirzepatide and Semaglutide Dosing begins low (0.25 mg with semaglutide or 2.5 mg with tirzepatide) and goes up gradually, this is called titration

The mechanism of action involves multiple pathways

By addressing key drivers of MASLD pathogenesis, GLP-1RAs may serve as effective pharmacological tools in managing the disease

The approval was expanded in October 2025 to include cardiovascular risk reduction in people with Type 2 diabetes